Work

Investigating the mechanism of bone marrow failure observed in patients with acute myeloid leukaemia

Year: 2018
Type: dissertation
Study design: Observational Study
Abstract: Patients with Acute Myeloid Leukaemia (AML) present with the signs and symptoms of bone marrow failure.This finding spans the genetic and phenotypic diversity of the disease.The mechanism which underlies it is poorly understood.This thesis explores the effect of AML on the normal haematopoietic stem cell (HSC) population, using primary human diagnostic bone marrow samples.Previous work from our group suggested that AML induces a state of quiescence in HSCs, producing a differentiation block responsible for the observed cytopenias 1 .Reversal of this process might offer an alternative to the current treatment of patients with palliative transfusions. I have developed a flow cytometry-based technique to differentiate normal HSCs from leukaemia cells, selecting cells with the CD34 + 38 -ALDH high CLL1 -expression signature.Validation of this technique by assessment of sorted cells by FISH and PCR, suggests it is successful in 73% of AML samples.In a further 25% of samples, it selects for a population significantly enriched for normal HSCs.We used this panel to investigate the concentration of HSCs at AML diagnosis, compared to controls.We show that there is no significant difference between HSC concentration at AML diagnosis (n=38, median [HSC] 2.5 cells/µl) and controls (n=24, median [HSC] 2.4 cells/µl).HSC concentration was not significantly affected by AML karyotype, patient age or gender.However, those patients presenting with a low HSC concentration at diagnosis (<0.1 HSC/µl) were found to have a significantly worse outcome both in terms of overall and relapse-free survival, an effect apparently independent of age, gender and underlying karyotype.HSC concentration at diagnosis with AML may therefore represent a new independent prognostic marker.We then studied CD33 expression patterns on HSCs within Core Binding Factor mutated AML (n=37) at diagnosis, and found its expression to be significantly lower than on HSCs within controls (n=9) (17% versus 58%, p=0.005).CD33 expression on HSCs from AML samples rose significantly from diagnosis to remission (n=16) (17% to 58%, p=0.0001).This mirrors previous findings from our group using CD34 low AML samples, and is, we believe, the first time that the antigenic signature of normal HSCs has been shown to be modified 8.1 Summary of main findings 8.2 Key areas for further experimental effort expanding on the work described within this thesis Does stem cell concentration at diagnosis have an independent prognostic impact?8.2.1 PARAMETER MALE FEMALE HAEMOGLOBIN (g/dL) 13.5-18.011.5-16.0PLATELETS (x10 9 /L) 150-400 150-400 WBC (x10 9 /L) 4.00-11.04.0-11.0NEUTROPHILS (x10 9 /L) 2.0-7.5 2.0-7.5 LYMPHOCYTES (x10 9 /L) 1.0-4.5 1.0-4.5 MONOCYTES (x10 9 /L) 0.2-0.80.2-0.8EOSINOPHILS (x10 9 /L) 0.04-0.40.04-0.4BASOPHILS (x10 9 /L) <0.1 <0.1 1.4.9.2 Phenotypic Identification of the LSC Improved efficiency of the initial xenograft transplant model (use of the NSG murine strain, or intrafemoral injection of transplanted cells), allowed experimental work which showed that LSC cells exist not just within the CD34 + 38 -fraction of bone marrow, but can share the phenotype of a more committed cell 129 .LSC phenotype can also vary dependant on the phenotypic appearance of the leukaemia: for example, in AML samples characterised by low expression of CD34, LSC activity is restricted to the CD34 -compartment, whereas in CD34 + AML samples, LSCs are found in both CD34 + and 34 -fractions 130 .A number of other antigens commonly expressed on LSCs have been reported.These are of interest both for the experimental identification of LSCs and also their therapeutic targeting 131,132 .The most valuable targets are those which are differentially expressed on LSCs and normal HSCs.1.5 Why does the development of AML lead to a failure of normal haematopoiesis?How does the mechanism of AML-associated bone marrow failure compare 8.3.1 with that seen in other malignancies?This project focussed very specifically on the interaction of AML with normal bone marrow, or more specifically, the HSC population within it.However, failure of haematopoiesis is not simply a phenomenon observed in AML: although clinical experience suggests it is synonymous with AML development, it also occurs with other haematological diseases such as ALL, the chronic leukaemias, myeloma and lymphomas (with significant bone marrow involvement), as well as several forms of metastatic carcinoma.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: green
OpenAlex ID: W2899999368
Cites: 356
Cited by:
Related to: 10